CIK 0001346830
- Non-accelerated filer
- Smaller reporting company
Tvardi Therapeutics, Inc.
Sign in to watch- Ticker
- TVRD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 713-489-8654
- Business address
- 3 SUGAR CREEK CTR. BLVD., STE 525, SUGAR LAND, TX, 77478
- Former names
- Cara Therapeutics, Inc., Cara Therapeutics Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-04 | Ives Jeffrey L. Director | Grant or award · Stock Option (Right to Buy) | +195,000 | 195,000 | ||
| 2024-06-04 | Shiff Susan Ph.D. Director | Grant or award | +150,647 | 202,085 | ||
| 2024-06-04 | Shiff Susan Ph.D. Director | Grant or award · Stock Option (Right to Buy) | +195,000 | 195,000 | ||
| 2024-06-04 | VOGELBAUM MARTIN Director | Grant or award | +301,295 | 411,007 | ||
| 2024-06-04 | VOGELBAUM MARTIN Director | Grant or award · Stock Option (Right to Buy) | +390,000 | 390,000 | ||
| 2024-05-02 | Posner Christopher PRESIDENT AND CEO | Sale | −3,936 | $0.75 | $3K | 176,585 |
| 2024-04-05 | Goncalves Joana CHIEF MEDICAL OFFICER | Sale | −2,753 | $0.83 | $2K | 53,365 |
| 2024-04-05 | Terrillion Scott SEC'Y; CHIEF COMPLIANCE & G.C. | Sale | −2,753 | $0.83 | $2K | 88,247 |
| 2024-02-29 | Terrillion Scott SEC'Y; CHIEF COMPLIANCE & G.C. | Sale | −3,293 | $0.89 | $3K | 91,000 |
| 2024-02-29 | Posner Christopher PRESIDENT AND CEO | Sale | −5,834 | $0.89 | $5K | 180,521 |
| 2024-02-29 | Goncalves Joana CHIEF MEDICAL OFFICER | Sale | −3,293 | $0.89 | $3K | 56,118 |
| 2024-02-08 | Posner Christopher PRESIDENT AND CEO | Sale | −35,575 | $0.53 | $19K | 186,355 |
| 2024-02-01 | Terrillion Scott SEC'Y; CHIEF COMPLIANCE & G.C. | Grant or award | +13,500 | 102,063 | ||
| 2024-02-01 | Maynard Ryan D CHIEF FINANCIAL OFFICER | Grant or award | +13,500 | 13,500 | ||
| 2024-02-01 | Goncalves Joana CHIEF MEDICAL OFFICER | Grant or award | +13,500 | 67,181 | ||
| 2024-02-01 | Menzaghi Frederique Ph.D. CHIEF SCIENTIFIC OFF,SVP-R&D | Grant or award | +13,500 | 167,247 | ||
| 2024-02-01 | Posner Christopher PRESIDENT AND CEO | Grant or award | +62,500 | 226,911 | ||
| 2024-02-01 | Posner Christopher PRESIDENT AND CEO | Sale | −4,981 | $0.55 | $3K | 221,930 |
| 2023-11-02 | Posner Christopher President and CEO | Sale | −3,796 | $1.22 | $5K | 164,411 |
| 2023-08-03 | Posner Christopher President and CEO | Sale 10b5-1 | −4,307 | $3.07 | $13K | 168,207 |
Page 4 of 7 · 123 trades